Showing 461-470 of 1539 results for "".
What's the most important thing you do each morning to start your day?
https://practicaldermatology.com/topics/general-topics/what-s-the-most-important-thing-you-do-each-morning-to-start-your-day--xvibvixd/18551/Besides drinking a large cup of coffee, listen to what Terrence Keaney, MD says he makes sure to do every morning that helps him maintain a good work-life balance.5 Ideas to Strengthen Your Dermatology Mobile Marketing
https://practicaldermatology.com/topics/practice-management/5-ideas-to-strengthen-your-dermatology-mobile-marketing/20873/Mobile search has made dramatic strides in recent years. It is time to boost your dermatology online exposure through mobile marketing.Biosimilars: What's Coming for Labeling?
https://practicaldermatology.com/topics/practice-management/biosimilars-whats-coming-for-labeling/20934/The public comment period on draft labeling guidance will end next month.Stevens-Johnson Syndrome: A Case Report
https://practicaldermatology.com/youngmd-connect/resident-resource-center/stevens-johnson-syndrome-a-case-series/23902/Successful treatment of drug-induced Stevens-Johnson Syndrome using cyclosporine and etanercept.Phase 2 and 3 Trials of JAK Inhibitors For Atopic Dermatitis: A Review
https://practicaldermatology.com/topics/atopic-dermatitis/phase-2-and-3-trials-of-jak-inhibitors-for-atopic-dermatitis-a-review/23265/A number of drugs in development show promise for one of the most challening skin diseases.DermWireTV: Diagnosing Melanoma Using Deep-Learning Model; New Adbry Approval
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-diagnosing-melanoma-using-deep-learning-model-new-adbry-approval/26445/In this week's DermWireTV, researchers develop a novel deep-learning model designed to more accurately diagnose melanoma; LEO Pharma receives a new approval for atopic dermatitis drug Adbry; and in our PA Perspectives segment, Andrew Mastro discusses how to build an inflammatory clinic.How New Molluscum Contagiosum Treatments Will Boost QoL and Limit Infection
https://practicaldermatology.com/topics/pediatric/how-new-molluscum-contagiosum-treatments-will-boost-qol-and-limit-infection/20244/Adam Friedman, MD, George Washington School of Medicine discusses the first FDA-approved nitric-oxide based drug in dermatology plus other recent approvals that he believes will make patients lives much easier and reduce the continuity of this condition.Six simple tips for an excellent dermatology website design
https://practicaldermatology.com/topics/practice-management/six-simple-tips-for-an-excellent-dermatology-website-design/20068/Is your website design outdated? Are you dreading the redesign? If so, check out this short video from Ekwa Marketing (www.ekwa.com) for tips on making the most of your redesign.In Demand: Non-invasive Body Contouring
https://practicaldermatology.com/topics/general-topics/in-demand-non-invasive-body-contouring/20738/A look at what's driving growth and important factors in managing patient expectations for non-invasive fat reduction treatments.Marketing Tips: WIFM?
https://practicaldermatology.com/topics/practice-management/marketing-tips-wifm/19060/When you want to succeed, think about "What's in it for me?"--from the patient perspective. IF Marketing's Tracy Drumm explains.